CSIMarket
 

Bellerophon Therapeutics inc  (BLPH)
Other Ticker:  
 

Bellerophon Therapeutics Inc's Working Capital Per Sales

BLPH's Working Capital and Revenue growth



BLPH Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change -41 % -30.55 % -11.22 % -89.41 % -72.02 %
Y / Y Revenue Change - - - - -
Working Capital Per Revenue 1.21 1.33 1.48 - -
Total Ranking # # # # #
Seq. Working Capital Change -49.35 % -39.62 % 513.92 % -68.58 % -40.38 %
Seq. Revenue Change - - - - -





Comment on BLPH's Working Capital Per Revenue in the third quarter 2023
Bellerophon Therapeutics Inc's Working Capital Per Revenue in the Q3 2023 sequentially fell to 1.21 but remained above Bellerophon Therapeutics Inc's average.

Within Healthcare sector Bellerophon Therapeutics inc has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q3 2023 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Per Revenue Statistics
High Average Low
0
0
0
 



Financial Statements
Bellerophon Therapeutics Inc's Working Capital $ 4 Millions Visit BLPH's Balance sheet
Bellerophon Therapeutics Inc's Revenues $ 0 Millions Visit BLPH's Income Statement
Where are BLPH's Sales coming from? Visit BLPH's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Neurometrix Inc   3.31 
Nurix Therapeutics Inc   3.26 
Cvrx inc  3.14 
Tivic Health Systems Inc   3.12 
Denali Therapeutics Inc   3.06 
Quanterix Corp  3.05 
Cartesian Therapeutics Inc   2.88 
Insmed Inc  2.86 
Therapeuticsmd Inc   2.83 
Bionano Genomics Inc   2.82 
Iterum Therapeutics Plc  2.77 
Neuroone Medical Technologies Corporation  2.70 
Regenxbio Inc   2.67 
Eyepoint Pharmaceuticals Inc   2.60 
Apellis Pharmaceuticals Inc   2.47 
Biocardia Inc  2.36 
Aurinia Pharmaceuticals Inc   2.34 
Carisma Therapeutics Inc   2.32 
Schrodinger Inc   2.31 
Cryoport inc   2.31 
Pulmonx Corporation  2.30 
Aravive Inc   2.23 
Precision Biosciences Inc  2.23 
Deciphera Pharmaceuticals Inc   2.22 
Adaptive Biotechnologies Corporation  2.21 
Adaptimmune Therapeutics Plc  2.21 
Sight Sciences Inc   2.13 
Nuo Therapeutics Inc   2.11 
Travere Therapeutics Inc   2.11 
Dynavax Technologies Corporation  2.11 
Date modified: 2023-11-17T15:51:11+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com